The customization of APACHE II for patients receiving orthotopic liver transplants by Moreno, Rui
ICU = intensive care unit.
Critical Care    June 2002 Vol 6 No 3 Moreno
In this issue of Critical Care, Arabi and co-workers present
the results of the validation of a modified model of the Acute
Physiology and Chronic Health Evaluation (APACHE) II for
patients receiving orthotopic liver transplants [1]. They
retrospectively used data from 174 patients admitted to two
hospitals (King Fahad National Guard Hospital in Riyadh,
Saudi Arabia, and the University of Wisconsin Madison, WI,
USA) to validate the modification of the APACHE II
prognostic model described by Derek Angus and colleagues
[2]. Is the approach of Arabi and co-workers correct? Can the
results and the approach be generalized to other settings?
The APACHE prognostic systems
Described in 1985 [3], the APACHE II prognostic system is
one of the most widely used general outcome models.
Developed for use with unselected groups of critically ill
adults, the system uses three types of data to provide the
user with a probability of death at hospital discharge: these
date are the Acute Physiology Score (APS), based on the
most deranged physiological and laboratory values during
the first 24 hours in the intensive care unit (ICU); the
premorbid status, based on a list of chronic diseases and
conditions apparent at admission to hospital; and the
diagnostic category, based on a list of 29 medical and 24
surgical diagnoses.
Because the system was developed in the early 1980s,
several diseases and conditions were not well represented in
the original database. This fact, together with major changes
in the outcome of major diseases and the need to
incorporate other variables, led the authors to undertake a
major update, the APACHE III prognostic system, published
in 1991 [4]. This updated system, being commercial, has not
had the impact of its free predecessor. With better
calibration, probably reflecting more the updated database
than major changes in the statistical construct of the model, it
was found to be quite well calibrated for the USA [5], except
in diagnostic groups for which major changes have been
made to the therapeutic approach, such as acute myocardial
infarction. In other settings, such as Spain, calibration
problems remained, prompting a major recalibration or
customization of the Apache III system [6].
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Abstract
General outcome prediction models developed for use with large, multicenter databases of critically ill
patients may not correctly estimate mortality if applied to a particular group of patients that was under-
represented in the original database. The development of new diagnostic weights has been proposed
as a method of adapting the general model — the Acute Physiology and Chronic Health Evaluation
(APACHE) II in this case — to a new group of patients. Such customization must be empirically tested,
because the original model cannot contain an appropriate set of predictive variables for the particular
group. In this issue of Critical Care, Arabi and co-workers present the results of the validation of a
modified model of the APACHE II system for patients receiving orthotopic liver transplants. The use of
a highly heterogeneous database for which not all important variables were taken into account and of a
sample too small to use the Hosmer–Lemeshow goodness-of-fit test appropriately makes their
conclusions uncertain.
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The customization of an outcome prediction
model
Customization — that is, modification of the equations that
transform a score (or the directly measured variables) to a
probability of mortality — has been suggested as a possible
approach when there is evidence that a given model is not
fully appropriate and an unbiased estimation of mortality is
needed. Preliminary work [7,8] showed that slight
modifications of the logistic regression equations would
suffice. Later, Zhu et al., working with computer simulations
[9], and groups using independent databases [10,11]
showed that customization was feasible and would improve
the calibration of the model but that some problems would
remain, so that there would still be a need for independent
validation of the customized model.
This need for validation applies to the work by Angus and
colleagues [2] on the development of new coefficients for the
APACHE II system to adapt it to patients after liver
transplantation. Those authors’ approach, which was to
develop a new diagnostic weighting for this category of
patients, is attractive, because it is simple. However, it
assumes that the APACHE II model incorporates the most
important prognostic variables in the setting of liver
transplantation, and this assumption needs to be justified.
Does the paper by Arabi and colleagues
answer our questions?
It does not. The work done by Arabi and his co-workers was
based on a highly heterogeneous database, and patients were
treated in two very different institutions. Differences in the
prevalence of chronic conditions and the degree of physiologic
disorder as well as differences in the procedures followed
during the liver transplantation (liver nutrition solutions, cold
ischemia time, etc.) could have influenced the outcome for
these patients. Moreover, the small number of patients in the
sample analyzed makes the Hosmer–Lemeshow goodness-of-
fit test underpowered to reveal potential differences between
the predicted and the actual mortality. The better calibration of
the customized model is promising, but it should be empirically
tested in a larger database, constructed to reflect the case mix
of liver transplantation patients.
For the moment, therefore, it remains to be shown whether the
approach used — to derive a new coefficient for the APACHE II
system to be applied to a specific group of patients — is
potentially useful and will perform better than its predecessor.
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